ALMR compared with A: revenue, margins and what each company keeps, and the suppliers and customers both name

ALMRAlamar Biosciences, Inc.

Mkt capRevenueRevenue

AAgilent Technologies, Inc.

Mkt capRevenueRevenue

Compare

ALMRAlamar Biosciences, Inc.

AAgilent Technologies, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ALMR2 of 4 reports

Reportimpliedrealized× implied

Q3 FY26—▼−9.36%—

Q2 FY26—▲+30.65%—

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±7.9%▲+1.68%×0.22

Q2 FY26±7.7%▲+16.87%×2.19

= impliedALMR realized, solidA realized, hatchedOne scale, both sides: full bar = 31%× = |realized| ÷ impliedspan: ALMR 85d · A 275dSource: market data

Q1 FY26

±6.4%

▼−3.01%

×0.47

Nov 25 '25±6.5%▲+2.34%×0.35

ALMRAlamar Biosciences, Inc.

27.20▲+1.10%

Mkt cap$1.9BRevenue$34MQ3 FY26Revenue—

AAgilent Technologies, Inc.

175.11▲+1.94%

Regular sessionNov 6 '26

Mkt cap$49.9BRevenue$1.9BQ3 FY26Revenue$6.9BFY25

Compare

Regular sessionNov 6 '26

ALMRAlamar Biosciences, Inc.

AAgilent Technologies, Inc.

27.20▲+1.10%

Price

175.11▲+1.94%

$1.9B

Mkt cap

$49.9B

Q3 FY26$34M

Revenue

$1.9BQ3 FY26

—

Revenue

$6.9BFY25

ALMR27.20▲+1.10%vsA175.11▲+1.94%Regular sessionNov 6 '26